Face the Facts: Stroke is Treatable
Every two seconds, someone in the world is having a stroke. Globally, stroke is the leading cause of disability and the second leading cause of death.
The right stroke care can save lives, but globally, not everyone has equal access to life-saving treatment.
Today, on World Stroke Day (Saturday 29 October 2016) the World Stroke Organisation is calling for global action to reduce inequality in stroke treatment to help save millions of lives.
“I invite the world to join us in the fight against stroke by taking action, driving awareness and pushing for better access to stroke treatments. Together we can conquer stroke,” said WSO President Stephen Davis from the World Stroke Congress in Hyderabad, India.
More than 17 million strokes occur globally each year with over 6 million deaths. The global challenge is huge with 26 million stroke survivors, many living with significant disabilities. One in six people will have a stroke in their lifetime.
The World Stroke Organisation calls on governments to take action to increase equity of access to critical stroke treatments, particularly for women and in low income communities. Improving stroke care will reduce the costly impact of stroke on healthcare systems around the world.
Despite evidence of some decline in stroke rates in high income settings, the global burden of stroke continues to expand, particularly driven by increased rates in low and middle income countries. This has been termed the “stroke pandemic”.
In low and middle income countries, precise data are often lacking, but evidence suggests the majority of patients cannot even access basic evidence-based therapies such as stroke unit care, thrombolysis or low-cost preventative medications.
Even in high income settings, where there are more robust data, large differences in quality of care are evident.
The WSO continually strives to build and strengthen local advocacy capacity through training to help address some of these inequities.
A ‘Roadmap to Delivering Quality Stroke Care’ guide was developed by WSO to assist health care professionals, governments and healthcare system decision-makers in delivering best practice stroke care with evidence-based treatments.
“The ethos of the Roadmap is that even with limited resources you can do something to improve stroke outcomes,” said incoming WSO President, Professor Werner Hacke.
“I call on individuals, families, communities, health professionals and governments to come together in the fight against stroke and improve access to life-saving stroke treatments, he added.
“This October, please join the 2016 World Stroke Campaign to spread the message globally to ‘Face the facts: stroke is treatable’ . Together, we can make a great impact and help people around the world access to the stroke treatment they deserve,” urged Professor Davis. Watch video: https://www.youtube.com/watch?v=fxUF3tuEJ7A
For more information visit www.worldstrokecampaign.org to register your World Stroke Day events or download campaign resources.
About World Stroke Day
Established by the World Stroke Organization (www.world-stroke.org ) in 2006, World Stroke Day is observed worldwide on October 29 to underscore the serious nature and high rates of stroke, raise awareness of the prevention and treatment of the condition, and ensure better care and support for survivors.
Join the World Stroke Campaign via social media: Facebook: @worldstrokecampaign Twitter : @WStrokeCampaign #WSD16 to learn the signs of stroke F.A.S.T. (F ace drooping; A rm weakness; S peech slurred; T ime to call an ambulance); and advocate for access to these evidence-based treatments regardless of economic setting: specialised stroke care units; tPA (intravenous thrombolysis); and mechanical thombectomy.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PIERRE-FABRE23.6.2018 13:02 | pressemeddelelse
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress
SERVIER23.6.2018 10:12 | pressemeddelelse
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho
SOFTOMOTIVE22.6.2018 17:15 | pressemeddelelse
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA
TX-ASCEND-PERFORMANCE22.6.2018 16:02 | pressemeddelelse
Ascend Performance Materials Announces Price Increase for Intermediate Materials
DELTICOM-AG/MOTO-TYRES.C22.6.2018 15:43 | pressemeddelelse
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk
BOEHRINGER-INGELHEIM22.6.2018 14:02 | pressemeddelelse
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum